Consainsights logo
Reports / Prophylactic HIV Drugs Market

Prophylactic HIV Drugs Market

Prophylactic HIV Drugs Market Research Report – Segmented By Drug (Emtricitabine, Other Drugs, Tenofovir), Dosage Form (Oral, Topical) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Prophylactic HIV Drugs Market from Consainsights analyses the Prophylactic HIV Drugs Market in the Life Sciences industry over the forecast period to 2026.

Prophylactic HIV Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Prophylactic HIV Drugs segmentation includes Drug, Dosage Form and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug, the Prophylactic HIV Drugs Market analysis covers Emtricitabine, Other Drugs, Tenofovir.

Based on the Dosage Form, the Prophylactic HIV Drugs Market analysis covers Oral, Topical.

Key companies operating in the market include AbbVie, APOTEX INC., Auro Pharma Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Inc., GalaxoSmithKline PLC, Genentech Inc., Gilead Sciences Inc., Johnson & Johnson Health Care Systems Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Teva Pharmaceutical Industries Ltd, ViiV Healthcare Group of Companies and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Drug (2019)
    Revenue Share (%), By Drug (2019)
  • Revenue Share (%), By Dosage Form (2019)
    Revenue Share (%), By Dosage Form (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Drug

By Drug, The Global Prophylactic HIV Drugs Market analysis covers Emtricitabine, Other Drugs, Tenofovir.

Global Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug, 2019-2027
Global Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug, 2019-2027

The Emtricitabine segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Emtricitabine: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
Emtricitabine: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)

The Other Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Drugs: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
Other Drugs: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)

The Tenofovir segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Tenofovir: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
Tenofovir: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
04

By Dosage Form

By Dosage Form, The Global Prophylactic HIV Drugs Market analysis covers Oral, Topical.

Global Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Dosage Form, 2019-2027
Global Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Dosage Form, 2019-2027

The Oral segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Oral: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
Oral: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)

The Topical segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Topical: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
Topical: Global Prophylactic HIV Drugs Market Revenue Opportunity (Us$ Mn)
05

North America

Based on the North America, the Prophylactic HIV Drugs Market analysis covers United States, Canada.

North America Map
North America Prophylactic HIV Drugs Market Size, 2019-2027 (Us$ Mn)
North America Prophylactic HIV Drugs Size, 2019-2027 (Us$ Mn)
North America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
North America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
North America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
North America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
United States Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
United States Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
United States Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
United States Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Canada Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Canada Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Canada Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Canada Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
06

Europe

Based on the Europe, the Prophylactic HIV Drugs Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Prophylactic HIV Drugs Market Size, 2019-2027 (Us$ Mn)
Europe Prophylactic HIV Drugs Size, 2019-2027 (Us$ Mn)
Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Germany Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Germany Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Germany Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Germany Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
United Kingdom Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
United Kingdom Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
United Kingdom Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
United Kingdom Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
France Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
France Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
France Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
France Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Spain Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Spain Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Spain Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Spain Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Russia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Russia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Russia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Russia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Italy Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Italy Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Italy Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Italy Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Europe Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
07

Asia-Pacific

Based on the Asia-Pacific, the Prophylactic HIV Drugs Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Prophylactic HIV Drugs Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Prophylactic HIV Drugs Size, 2019-2027 (Us$ Mn)
Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
China Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
China Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
China Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
China Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Japan Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Japan Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Japan Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Japan Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
India Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
India Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
India Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
India Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Southeast Asia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Southeast Asia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Southeast Asia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Southeast Asia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Australia & New Zealand Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Australia & New Zealand Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Australia & New Zealand Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Australia & New Zealand Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Asia-Pacific Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Prophylactic HIV Drugs Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Prophylactic HIV Drugs Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Prophylactic HIV Drugs Size, 2019-2027 (Us$ Mn)
Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Middle East Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Middle East Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Middle East Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Middle East Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Middle East & Africa Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
09

Latin America

Based on the Latin America, the Prophylactic HIV Drugs Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Prophylactic HIV Drugs Market Size, 2019-2027 (Us$ Mn)
Latin America Prophylactic HIV Drugs Size, 2019-2027 (Us$ Mn)
Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Brazil Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Brazil Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Brazil Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Brazil Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Argentina Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Argentina Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Argentina Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Argentina Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Mexico Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Mexico Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Mexico Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Mexico Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Colombia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Colombia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Colombia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Colombia Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug, 2019-2027
Rest of Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
Rest of Latin America Prophylactic HIV Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Dosage Form, 2019-2027
10

Company Analysis

  • AbbVie
  • APOTEX INC.
  • Auro Pharma Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • GalaxoSmithKline PLC
  • Genentech Inc.
  • Gilead Sciences Inc.
  • Johnson & Johnson Health Care Systems Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • ViiV Healthcare Group of Companies